Zura Bio Ltd (ZURA) stock
ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.93−0.02 (-2.30%)
Close on Nov 20, 2026Market cap $89.63MP/E –Yield –
Zura Bio cash
Cash and short-term investments held at the end of each period.
Zura Bio's cash was $187.65M at Sep 30, 2026. For fiscal 2025 it was $109.41M, up 61887.7% from the year before. The highest annual figure on record is $109.41M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.41M | +61887.7% |
| FY2024 | Dec 31, 2024 | $176.50K | -99.8% |
| FY2023 | Dec 31, 2023 | $99.81M | +6269.2% |
| FY2022 | Dec 31, 2022 | $1.57M | +114.9% |
| FY2021 | Dec 31, 2021 | $729.22K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $187.65M | +134884.9% |
| Q2 FY2026 | Jun 30, 2026 | $205.13M | +132681.4% |
| Q1 FY2026 | Mar 31, 2026 | $225.59M | +32.3% |
| Q4 FY2025 | Dec 31, 2025 | $109.41M | +61887.7% |
| Q3 FY2025 | Sep 30, 2025 | $139.02K | -99.9% |
| Q2 FY2025 | Jun 30, 2025 | $154.49K | -99.9% |
| Q1 FY2025 | Mar 31, 2025 | $170.57M | +89.9% |
| Q4 FY2024 | Dec 31, 2024 | $176.50K | -99.8% |
| Q3 FY2024 | Sep 30, 2024 | $188.22M | +81.2% |
| Q2 FY2024 | Jun 30, 2024 | $188.44M | +67.1% |
| Q1 FY2024 | Mar 31, 2024 | $89.82M | +104.3% |
| Q4 FY2023 | Dec 31, 2023 | $99.81M | +6269.2% |
| Q3 FY2023 | Sep 30, 2023 | $103.86M | +3306.3% |
| Q2 FY2023 | Jun 30, 2023 | $112.80M | +2456.7% |
| Q1 FY2023 | Mar 31, 2023 | $43.96M | +831.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.57M | +114.9% |
| Q3 FY2022 | Sep 30, 2022 | $3.05M | +209.0% |
| Q2 FY2022 | Jun 30, 2022 | $4.41M | +17565.0% |
| Q1 FY2022 | Mar 31, 2022 | $4.72M | +18798.9% |
| Q4 FY2021 | Dec 31, 2021 | $729.22K | – |
| Q3 FY2021 | Sep 30, 2021 | $986.65K | – |
| Q2 FY2021 | Jun 30, 2021 | $24.98K | – |
| Q1 FY2021 | Mar 31, 2021 | $24.98K | – |
See a number that looks wrong?